Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Harbor BioSciences ( (HRBR) ) is now available.
On January 9, 2026, Harbor Diversified, Inc. completed the sale of its remaining airline-related operating assets under a series of purchase agreements with CSI Aviation, Inc. and UMB Bank, after receiving U.S. Department of Transportation approval on January 5, 2026, for total consideration of about $110 million subject to post-closing adjustments, leaving the company and its subsidiaries without material operating assets or airline infrastructure but retaining certain non-operating assets. In connection with the transaction, the board overhauled parts of the executive team effective January 9, 2026, appointing Gregg Garvey as Executive Vice President, Chief Financial Officer and Treasurer, and Chad Schimmelpfenning as Executive Vice President and Chief Legal Counsel, while former Air Wisconsin President and CEO Robert Binns departed and certain executives, including Binns, Garvey and Schimmelpfenning, received transaction-related cash bonuses. With its balance sheet now dominated by liquid investments and no material indebtedness, the board is actively reviewing strategic alternatives ranging from acquisitions in or outside the airline sector to dividends or a possible liquidation, though no decision has been made, and the company expects to outline its chosen direction in future regulatory filings. Separately, Harbor Diversified reported a favorable outcome in the consolidated securities class action Toft v. Harbor Diversified, Inc., et al., in which the operative complaint was dismissed on January 31, 2025, and the court on December 3, 2025, granted Rule 11 sanctions against one plaintiffs’ law firm, with the court to determine the amount of attorneys’ fees and costs owed to the company and certain officers. Despite these developments, the company remains out of compliance with its SEC periodic reporting obligations under Section 15(d) of the Exchange Act due to delayed filings, a situation it intends but does not guarantee to remedy, acknowledging that ongoing noncompliance could erode investor confidence, damage its reputation, and complicate future strategic transactions.
More about Harbor BioSciences
Harbor Diversified, Inc., formerly focused on airline operations through subsidiaries such as Air Wisconsin, has now effectively exited the airline industry. Following the sale of substantially all aviation-related operating assets, the company’s primary holdings consist of cash and cash equivalents, restricted cash, marketable securities, and certain residual non-operating assets, positioning it as a cash-rich vehicle evaluating new strategic directions across potentially multiple industries.
Average Trading Volume: 66,459
Technical Sentiment Signal: Buy
Current Market Cap: $101.7M
For a thorough assessment of HRBR stock, go to TipRanks’ Stock Analysis page.